Clinical Trial Update: Preventing Sickle Cell Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on preventing sickle cell kidney disease; status terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Sickle Cell
• Hypertension
• Kidney Disease
• Proteinuria
• Sickle Cell Disease

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Anemia, Sickle Cell, Sickle Cell Disease | Phase 2 | Status: TERMINATED | Results posted: 2022-05-09